http://thefederalregister.com/b.p/agency/Food_and_Drug_Administration/2003-12-02/ Daily Publications of Meetings and Rules Changes for the Federal Government Sun, Nov 23 2008 11:00:00 GMT Sun, Nov 23 2008 11:00:00 GMT info@thefederalregister.com http://thefederalregister.com/d.p/2003-12-02-03-29863 ]]> http://thefederalregister.com/d.p/2003-12-02-03-29863 Tue, Dec 2 2003 11:00:00 GMT http://thefederalregister.com/d.p/2003-12-02-03-29928 ]]> http://thefederalregister.com/d.p/2003-12-02-03-29928 Tue, Dec 2 2003 11:00:00 GMT http://thefederalregister.com/d.p/2003-12-02-03-29929 ]]> http://thefederalregister.com/d.p/2003-12-02-03-29929 Tue, Dec 2 2003 11:00:00 GMT http://thefederalregister.com/d.p/2003-12-02-03-29927 the regulatory review period for LEXAPRO and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of an application to the Director of Patents and Trademarks, Department of Commerce, for the extension of a patent that claims that human drug product. ]]> http://thefederalregister.com/d.p/2003-12-02-03-29927 Tue, Dec 2 2003 11:00:00 GMT http://thefederalregister.com/d.p/2003-12-02-03-30076 ]]> http://thefederalregister.com/d.p/2003-12-02-03-30076 Tue, Dec 2 2003 11:00:00 GMT http://thefederalregister.com/d.p/2003-12-02-03-29864 ]]> http://thefederalregister.com/d.p/2003-12-02-03-29864 Tue, Dec 2 2003 11:00:00 GMT http://thefederalregister.com/d.p/2003-12-02-03-29855 Recommendations for Drugs of Abuse Screening Tests.'' This draft guidance is intended to assist industry in preparing premarket notification submissions for drugs of abuse screening tests. The draft guidance also provides recommendations regarding the labeling of these tests. This draft guidance is neither final nor is it in effect at this time. ]]> http://thefederalregister.com/d.p/2003-12-02-03-29855 Tue, Dec 2 2003 11:00:00 GMT http://thefederalregister.com/d.p/2003-12-02-03-30025 ]]> http://thefederalregister.com/d.p/2003-12-02-03-30025 Tue, Dec 2 2003 11:00:00 GMT